Healthy adult
Conditions
Interventions
Intake 6 capsules those contain 160mg eucalyptus extract for 12 weeks.
Intake 6 capsules those contain 320mg eucalyptus extract for 12 weeks.
Intake 6 capsules those contain 576mg eucalyptus extract f
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Males and females aged 20 to 64 at resistration. (2)Subjects whose body mass index (BMI) is 23.0 to 29.9 kg/m2. (3) Subjects whose have customs of eating snacks which containing fructose for more than 5 days a week (4)Subjects giving written informed consent.
Exclusion criteria
Exclusion criteria: 1)Subjects who are given continuous treatment by taking medicines. 2)Subjects who constantly use oral medicines, functional foods and/or supplements having a possibility of affecting test results. 3) Those who have a weak gastrointestinal. 4) Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney and/or digestive trucks. (5)Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney and/or digestive trucks. (6)Subjects who excessive alcohol intake. (7)Subjects who have extremely irregular life rhythm, and subjects who have midnight work or irregular shift work. (8)Subjects who have previous medical history of drug and/or food allergy. (9)Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within 4-weeks prior to the current study. Subjects who are planning to participate in other clinical tests of medicines or foods after agreeing with participating in this study. (10)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (11)Males who donated over 400mL blood within the last three month to the current study. (12) Females who donated over 400mL blood within the last four month to the current study. (13) Males who will be collected over 1200mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (14) Females who will be collected over 800mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (15) Subjects who are severely anemic, or who have been diagnosed with a severe anemia by the doctor (16)Others who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The inspection items at 6 and 12 weeks after beginning of ingestion of the test food as follows. body weight, BMI, body fat percentage, visceral fat area. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of side effects and adverse events. | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Planning & Sales Department
Outcome results
None listed